PET imaging agent PyL meets primary endpoint in phase III prostate cancer trial Dec. 24, 2019 No Comments
89Zr-DFO-MSTP-2109A shows promise as companion diagnostic in patients with mCRPC Dec. 4, 2019 No Comments
APRINOIA Therapeutics describes compounds targeting microtubule-associated protein tau Nov. 26, 2019 No Comments
RSS